Portfolio company
Llusern Scientific
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops portable molecular diagnostic platforms and urinary tract infection testing kits for professional healthcare and veterinary providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
FluoretiQ Limited
This company develops rapid point-of-care diagnostic tests that identify bacterial infections and antibiotic sensitivity for clinicians and veterinarians.
Alveo
This company develops portable molecular diagnostic platforms for rapid pathogen detection in agriculture, food safety, environmental monitoring, and human healthcare sectors.
DxLab
This company develops point-of-care molecular testing systems and rapid diagnostic tests for pathogens to serve healthcare providers and public health teams.
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
MyUTI
This company provides diagnostic laboratory testing kits and telehealth services for individuals suffering from urinary tract infections and related pelvic health issues.
Abacus Diagnostica
This company develops molecular diagnostic systems for infectious disease testing, serving hospital laboratories and healthcare units.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
Limosa Immunodiagnostics
This company develops diagnostic tests for latent tuberculosis and other immune-related diseases for patients and healthcare providers.
